YOLFTbeta
MEDIANA Co.Ltd

MEDIANA Co.Ltd

041920 · KQ · Healthcare / Healthcare Equipment & Supplies

7,690.00KRW+80.00 (+1.05%)

Price History

Full chart

Market Stats

Previous Close7,610.00
Open7,710.00
Day Range7,460.00 – 7,800.00
52-Week Range4,850.00 – 29,600.00
Volume53.96K
Market Cap186.17B
P/E (TTM)0.00
Forward P/E0.00
Dividend Yield0.00%
Beta-0.18
50-Day Avg8,900.80
200-Day Avg14,757.30

About

Mediana Co.,Ltd, together with its subsidiaries, develops, manufactures, and sells medical devices in South Korea. It offers patient monitors, vital signs monitors, AEDs, monitors/defibrillators, fetal products, body composition analyzers, central monitoring systems, face masks, spot checks and monitors, pulse oximeters, and physio modules. The company also exports ODM and own branded products through agencies in approximately 80 countries. Mediana Co.,Ltd was founded in 1993 and is headquartered in Wonju-si, South Korea.

Company Details

  • SectorHealthcare
  • IndustryHealthcare Equipment & Supplies
  • CEODr. Moon Jong Khil
  • Employees140
  • Headquarters132, Donghwagongdan-ro, Wonju-si, South Korea, Korea
  • Websitehttp://www.mediana.co.kr

Leadership

  • Dr. Moon Jong KhilChairman and Chief Exec. Officer
  • Dr. Simon KimChief Exec. Officer and Pres

Financials

Income Statement

Currency: KRW2014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue38.36B46.74B53.39B52.22B46.83B48.40B67.52B56.80B68.35B78.42B57.04B64.94B
Growth (%)-+21.86%+14.24%-2.20%-10.33%+3.36%+39.50%-15.87%+20.32%+14.74%-27.27%+13.86%
Cost of Revenue22.70B29.08B34.12B34.76B32.16B30.99B40.92B37.45B44.89B55.99B39.59B42.65B
Gross Profit13.95B17.66B19.27B17.46B14.67B17.41B26.59B19.36B23.46B22.44B17.45B22.29B
Gross Margin36.37%37.78%36.09%33.44%31.32%35.97%39.39%34.08%34.32%28.61%30.59%34.32%
Operating Expense9.67B9.74B11.14B12.94B12.28B9.91B11.46B11.14B12.85B13.03B16.14B16.34B
Operating Income4.28B7.92B8.13B4.53B2.38B7.50B15.13B8.21B10.61B9.40B1.31B5.95B
Operating Margin11.15%16.95%15.23%8.67%5.09%15.50%22.41%14.46%15.52%11.99%2.30%9.16%
EBITDA--------15.36B12.93B10.00B7.91B
EBITDA Margin--------22.48%16.49%17.53%12.18%
Net Income3.63B7.08B7.95B3.15B3.24B6.75B11.24B8.77B10.60B8.89B6.21B5.27B
Net Income Margin9.46%15.16%14.90%6.03%6.92%13.94%16.65%15.45%15.51%11.34%10.89%8.12%
R&D2.00B2.54B2.92B4.53B4.05B3.48B3.47B4.04B4.45B4.15B4.53B4.92B
R&D as % of Total Revenue5.20%5.44%5.47%8.68%8.65%7.19%5.14%7.11%6.51%5.29%7.95%7.58%
Interest Expense00000011.01M12.10M17.68M24.11M20.56M28.64M
Interest Expense % of Total Revenue0.00%0.00%0.00%0.00%0.00%0.00%0.02%0.02%0.03%0.03%0.04%0.04%

Balance Sheet

Currency: KRW2014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets37.02B44.44B54.29B52.98B56.79B64.76B76.76B90.17B103.45B111.92B139.56B146.84B
Total Liabilities9.73B9.53B11.54B9.16B7.34B7.82B8.45B11.43B13.38B11.28B11.76B11.40B
Total Equity27.30B34.91B42.75B43.82B49.44B56.94B68.31B78.74B90.06B100.64B127.80B135.43B
Cash10.57B9.39B11.32B8.98B8.88B15.79B21.70B69.00K328.00K35.52B62.00K26.94B
Total Debt--1.05B1.04B-67.39M169.71M-----

Cash Flow

Currency: KRW2014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow728.97M7.67B8.20B1.01B3.71B12.18B9.41B12.13B9.70B14.57B5.11B5.50B
Investing Cash Flow-35.24M-5.80B-7.02B-2.74B-3.51B-3.75B-2.42B-1.44B-16.95B-1.07B-40.62B-
Financing Cash Flow5.97B-3.10B561.81M-90.61M-329.65M-1.36B-126.12M-517.95M-724.65M-1.11B15.54B-
Capital Expenditure275.56M5.48B5.99B3.44B2.67B2.31B1.70B1.58B488.10M408.04M796.80M608.50M
Free Cash Flow-----5.35B7.69B10.37B9.21B14.16B4.31B4.90B
Dividends Paid-428.87M428.87M428.87M428.87M429.32M429.32M429.32M430.71M797.90M399.04M-
FCF to OCF-----43.93%81.70%85.44%94.97%97.20%84.39%88.94%
Dividend Paid to FCF-----8.02%5.59%4.14%4.68%5.64%9.26%-

Earnings

Report DateFeb 12, 2015Apr 20, 2015Jul 22, 2015Oct 26, 2015Jan 25, 2016Apr 20, 2016Jul 24, 2016Oct 25, 2016Jan 22, 2017Apr 21, 2017Jul 24, 2017Oct 24, 2017Jan 26, 2018Apr 26, 2018Jul 27, 2018Nov 4, 2018Jan 27, 2019Apr 28, 2019Jul 23, 2019Oct 24, 2019Feb 3, 2020Apr 27, 2020Jul 26, 2020Oct 26, 2020Jan 31, 2021Mar 31, 2021Jun 30, 2021Sep 30, 2021Dec 31, 2021Mar 31, 2022Jun 30, 2022Sep 30, 2022Dec 31, 2022Mar 31, 2023Jun 30, 2023Sep 30, 2023Jan 8, 2024Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
EPS Estimate-----------------------------------------------
EPS Actual87.6967.9388.88115.89172.62110.05145.2361.46194.3253.26166.38107.00-25.4119.2976.4931.4380.2783.53157.09153.0130.21228.73295.62190.43-7.88157.8787.31121.90183.19143.55198.79368.10-46.28147.96262.58169.22-22.46153.9782.62-62.95163.6283.83-23.31123.22102.07127.59168.50
Surprise-----------------------------------------------
TimingAfter-hoursPre-marketAfter-hoursPre-marketAfter-hoursPre-marketAfter-hoursAfter-hoursAfter-hoursPre-marketAfter-hoursPre-marketPre-marketPre-marketPre-marketAfter-hoursAfter-hoursAfter-hoursAfter-hoursPre-market-After-hoursAfter-hours-After-hours-----------Pre-market----------

Key Statistics & Ratios

Market Cap186.17B
Enterprise Value78.48B
Trailing P/E0.00
Forward P/E0.00
Price / Sales2.31
Price / Book1.16
Revenue (TTM)65.01B
Gross Profit (TTM)18.85B
EBITDA12.01B
Profit Margin21.93%
Operating Margin15.64%
Return on Equity395.48%
Return on Assets6.73%
Shares Outstanding8.56M
Shares Float9.89M
Beta-0.18
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Dividends

20231×
25.00Dec 27, 2023
20221×
50.00Dec 28, 2022
20211×
27.00Dec 29, 2021
20201×
26.97Dec 29, 2020
20171×
26.97Dec 27, 2017

Stock Splits

  • Oct 8, 20211483:800
  • Feb 11, 20166:5